Should Value Investors Buy Cardinal Health (CAH) Stock?
Werte in diesem Artikel
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.Cardinal Health (CAH) is a stock many investors are watching right now. CAH is currently sporting a Zacks Rank #2 (Buy) and an A for Value. The stock is trading with P/E ratio of 15.39 right now. For comparison, its industry sports an average P/E of 15.81. CAH's Forward P/E has been as high as 20.15 and as low as 13.69, with a median of 15.29, all within the past year. Investors will also notice that CAH has a PEG ratio of 1.23. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. CAH's PEG compares to its industry's average PEG of 1.63. Over the past 52 weeks, CAH's PEG has been as high as 1.88 and as low as 1.22, with a median of 1.49.Finally, investors will want to recognize that CAH has a P/CF ratio of 15.18. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 16.50. Within the past 12 months, CAH's P/CF has been as high as 17.70 and as low as 12.96, with a median of 15.12.These are just a handful of the figures considered in Cardinal Health's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that CAH is an impressive value stock right now.Higher. Faster. Sooner. Buy These Stocks NowA small number of stocks are primed for a breakout, and you have a chance to get in before they take off.At any given time, there are only 220 Zacks Rank #1 Strong Buys. On average, this list more than doubles the S&P 500. We’ve combed through the latest Strong Buys and selected 7 compelling companies likely to jump sooner and climb higher than any other stock you could buy this month.You'll learn everything you need to know about these exciting trades in our brand-new Special Report, 7 Best Stocks for the Next 30 Days.Download the report free now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cardinal Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Cardinal
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cardinal
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Cardinal Health Inc.
Analysen zu Cardinal Health Inc.
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
03.11.2015 | Cardinal Health Buy | UBS AG | |
03.11.2015 | Cardinal Health Outperform | FBR Capital | |
09.06.2015 | Cardinal Health Buy | UBS AG | |
10.03.2015 | Cardinal Health Outperform | FBR Capital | |
04.03.2015 | Cardinal Health Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen